Targeting UPR signaling pathway by dasatinib as a promising therapeutic approach in chronic myeloid leukemia

Articles > Article · 2022

Authors: Burçin KAYMAZ

MEDICAL ONCOLOGY, Journal Indexed in SCI Expanded, International, 2022, vol 39, pp 1-9